Cite
Cheung M, Bao W, Behm DJ, et al. Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4. ACS Med Chem Lett. 2017;8(5):549-554doi: 10.1021/acsmedchemlett.7b00094.
Cheung, M., Bao, W., Behm, D. J., Brooks, C. A., Bury, M. J., Dowdell, S. E., Eidam, H. S., Fox, R. M., Goodman, K. B., Holt, D. A., Lee, D., Roethke, T. J., Willette, R. N., Xu, X., Ye, G., & Thorneloe, K. S. (2017). Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4. ACS medicinal chemistry letters, 8(5), 549-554. https://doi.org/10.1021/acsmedchemlett.7b00094
Cheung, Mui, et al. "Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4." ACS medicinal chemistry letters vol. 8,5 (2017): 549-554. doi: https://doi.org/10.1021/acsmedchemlett.7b00094
Cheung M, Bao W, Behm DJ, Brooks CA, Bury MJ, Dowdell SE, Eidam HS, Fox RM, Goodman KB, Holt DA, Lee D, Roethke TJ, Willette RN, Xu X, Ye G, Thorneloe KS. Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4. ACS Med Chem Lett. 2017 Mar 20;8(5):549-554. doi: 10.1021/acsmedchemlett.7b00094. eCollection 2017 May 11. PMID: 28523109; PMCID: PMC5430398.
Copy
Download .nbib